Principle 2 of the Prokaryotic Code, as modified by the ICSP in 1999, reads: 'The nomenclature of prokaryotes is not independent of botanical and zoological nomenclature. When naming new taxa in the rank of genus or higher, due consideration is to be given to avoiding names which are regulated by the International Code of Zoological Nomenclature and the International Code of Nomenclature for algae, fungi and plants'. But in the current version of the Prokaryotic Code no Rule implements this version of Principle 2. I therefore propose adding the following sentence to Rule 10a: 'As from January 2001, newly proposed generic names must not be later homonyms of names in use in botany or zoology'. Recommendation 10a(3) of the Code states: 'Avoid introducing into bacteriology as generic names such names as are in use in botany or zoology, in particular well-known names'. This Recommendation contravenes the current version of Principle 2 and the proposed new version of Rule 10a. Therefore I propose to delete Recommendation 10a(3) from the Prokaryotic Code.
In the 1990 revision of the International Code of Nomenclature of Bacteria (ICNB) [1] , Principle 2 reads: 'The nomenclature of bacteria is independent of botanical nomenclature, except for algae and fungi, and of zoological nomenclature, except protozoa … "Independent" means that the same name may be validly used for a taxon of bacteria as well as a taxon of plants or animals …'. However, to discourage the formation of homonyms under the botanical and the zoological codes, Recommendation 10a(3) of the ICNB stated: 'Avoid introducing into bacteriology as generic names such names as are in use in botany or zoology, in particular well-known names'.
In 1999, Tindall [2] According to General Consideration 6 (1), the Principles form the basis of the Code, and the Rules and Recommendations are derived from them. The Rules are designed to make effective the Principles [General Consideration 6 (2)]. But in the current version of the ICNP there is no Rule that implements the new version of Principle 2, and without a relevant Rule, this Principle would remain ineffective. Therefore, I propose changing the text of Rule 10a as follows, also including two earlier proposals for modification that are awaiting to be discussed by the International Committee on Systematics of Prokaryotes and its Judicial Commission [6, 7] :
RULE 10A
The name of a genus or subgenus is a substantive, or an adjective used as a substantive, in the singular number in the nominative case, and written with an initial capital letter. The name may be taken from any source and may even be composed in an arbitrary manner. It is treated as a Latin substantive. Words from languages other than Latin or Greek should be avoided as parts of genus or subgenus names as long as equivalents exist in Latin or Greek or can be constructed by combining word elements from these two languages. Exceptions can be made for names derived from typical local items such as foods, drinks or geographical localities for which no Latin or Greek names exist or for names based on acronyms.
Examples: Single Greek stem, Clostridium; two Greek stems, Haemophilus; single Latin stem, Spirillum; two Latin stems, Lactobacillus; hybrid name, Latin-Greek stems, Flavobacterium; latinized personal name, Shigella; arbitrary name, Afipia, Desemzia, Waddlia, or Cedecea.
As from January 2001, newly proposed generic names must not be later homonyms of names in use in botany or zoology (see Principle 2).
Recommendation 10a(3) was retained in the 2008 revision of the ICNP [5] in spite of the fact that this Recommendation contravenes the modified Principle 2. According to General Consideration 6 (3) of the ICNP, the Recommendations are intended to be guides to desirable practice in the future, but names contrary to a Recommendation cannot be rejected for this reason. This implies that based on this Recommendation, newly created prokaryotic genus names with homonymy with botanical and zoological genus names can still be legitimate under the ICNP. As Recommendation 10a (3) is incompatible with the newly proposed version of Rule 10a, I propose to delete Recommendation 10a(3) from the ICNP so that Principle 2 and the modified Rule 10a can be effectively implemented.
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